scholarly journals Persistent homology of tumor CT scans is associated with survival in lung cancer

2021 ◽  
Author(s):  
Eashwar Somasundaram ◽  
Adam Litzler ◽  
Raoul Wadhwa ◽  
Steph Owen ◽  
Jacob Scott
2020 ◽  
Author(s):  
Eashwar Somasundaram ◽  
Adam Litzler ◽  
Raoul R. Wadhwa ◽  
Jacob G. Scott

ABSTRACTRadiomics, the objective study of non-visual features in clinical imaging, has been useful in informing decisions in clinical oncology. However, radiomics currently lacks the ability to characterize the overall structure of the data. This field may benefit by incorporating persistent homology, a popular new algorithm that analyzes whole data structure. We hypothesized that persistent homology could be applied to lung tumor scans and predict clinical variables. We obtained computed tomography lung scans (n = 565) from the NSCLC-Radiomics and NSCLC-Radiogenomics datasets in The Cancer Imaging Archive. Segmentation data was used to create a cubical region centered on the primary tumor in each scan. For each scan, a cubical complex filtration based on Hounsfield units was generated. We created a feature curve that plotted the number of 0 dimensional topological features against each Hounsfield unit. The curve’s first moment of the distribution was utilized as a summary statistic to predict survival in a Cox proportional hazards model. The first moment of the distribution is equivalent to the area under the curve of our topological feature curves (AUC). The Kruskal-Wallis H Test and a post-hoc Dunn’s test with Bonferroni correction were used to test AUC differences among survival quartiles. After controlling for tumor image size, age, and stage, AUC, was associated with poorer survival (HR = 1.118; 95% CI = 1.026-1.218; p = 0.01). AUC was significantly higher for patients in the lowest survival quartile compared to the highest survival quartile (p < 0.001). We have shown that persistent homology can generate useful clinical correlates from tumor CT scans. Our 0-dimensional topological feature curve statistic predicts survival in lung cancer patients. This novel statistic may be used in tandem with standard radiomics variables to better inform clinical oncology decisions.


2014 ◽  
Vol 42 (1) ◽  
pp. 391-399 ◽  
Author(s):  
Alexandra R. Cunliffe ◽  
Clay Contee ◽  
Samuel G. Armato ◽  
Bradley White ◽  
Julia Justusson ◽  
...  

2013 ◽  
Vol 51 (4) ◽  
pp. 205-206 ◽  
Author(s):  
James R. Jett
Keyword(s):  
Low Dose ◽  
Ct Scans ◽  

2021 ◽  
Author(s):  
Babak Haghighi ◽  
Hannah Horng ◽  
Peter B Noël ◽  
Eric Cohen ◽  
Lauren Pantalone ◽  
...  

Abstract Rationale: High-throughput extraction of radiomic features from low-dose CT scans can characterize the heterogeneity of the lung parenchyma and potentially aid in identifying subpopulations that may have higher risk of lung diseases, such as COPD, and lung cancer due to inflammation or obstruction of the airways. We aim to determine the feasibility a lung radiomics phenotyping approach in a lung cancer screening cohort, while quantifying the effect of different CT reconstruction algorithms on phenotype robustness. Methods: We identified low-dose CT scans (n = 308) acquired with Siemens Healthineers scanners from patients who completed low-dose CT within our lung cancer screening program between 2015-2018 and had two different sets of image reconstructions kernel available (i.e., medium (I30f), sharp (I50f)) for the same acquisition. Following segmentation of the lung field, a total of 26 radiomic features were extracted from the entire 3D lung-field using a previously validated fully-automated lattice-based software pipeline, adapted for low-dose CT scans. The features extracted included gray-level histogram, co-occurrence, and run-length descriptors. Each feature was averaged for each scan within a range of lattice window sizes (W) ranging from 4-20mm. The extracted imaging features from both datasets were harmonized to correct for differences in image acquisition parameters. Subsequently, unsupervised hierarchal clustering was applied on the extracted features to identify distinct phenotypic patterns of the lung parenchyma, where consensus clustering was used to identify the optimal number of clusters (K = 2). Differences between? phenotypes for demographic and clinical covariates including sex, age, BMI, pack-years of smoking, Lung-RADS and cancer diagnosis were assessed for each phenotype cluster, and then compared across clusters for the two different CT reconstruction algorithms using the cluster entanglement metric, where a lower entanglement coefficient corresponds to good cluster alignment. Furthermore, an independent set of low-dose CT scans (n = 88) from patients with available pulmonary function data on lung obstruction were analyzed using the identified optimal clusters to assess associations to lung obstruction and validate the lung phenotyping paradigm. Results: Heatmaps generated by radiomic features identified two distinct lung parenchymal phenotype patterns across different feature extraction window sizes, for both reconstruction algorithms (P < 0.05 with K = 2). Associations of radiomic-based clusters with clinical covariates showed significant difference for BMI and pack-years of smoking (P < 0.05) for both reconstruction kernels. Radiomic phenotype patterns where similar across the two reconstructed kernels, specifically when smaller window sizes (W=4 and 8mm) were used for radiomic feature extraction, as deemed by their entanglement coefficient. Validation of clustering approaches using cluster mapping for the independent sample with lung obstruction also showed two statistically significant phenotypes (P < 0.05) with significant difference for BMI and smoking pack-years.ConclusionsRadiomic analysis can be used to characterize lung parenchymal phenotypes from low-dose CT scans, which appear reproducible for different reconstruction kernels. Further work should seek to evaluate the effect of additional CT acquisition parameters and validate these phenotypes in characterizing lung cancer screening populations, to potentially better stratify disease patterns and cancer risk.


2004 ◽  
Vol 60 (4) ◽  
pp. 1283-1290 ◽  
Author(s):  
René W.M. Underberg ◽  
Frank J. Lagerwaard ◽  
Johan P. Cuijpers ◽  
Ben J. Slotman ◽  
John R. van Sörnsen de Koste ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (1) ◽  
pp. e0169172 ◽  
Author(s):  
Elizabeth Huynh ◽  
Thibaud P. Coroller ◽  
Vivek Narayan ◽  
Vishesh Agrawal ◽  
John Romano ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (18) ◽  
pp. 4585
Author(s):  
Wouter R. P. H. van de Worp ◽  
Brent van der Heyden ◽  
Georgios Lappas ◽  
Ardy van Helvoort ◽  
Jan Theys ◽  
...  

Lung cancer is the leading cause of cancer related deaths worldwide. The development of orthotopic mouse models of lung cancer, which recapitulates the disease more realistically compared to the widely used subcutaneous tumor models, is expected to critically aid the development of novel therapies to battle lung cancer or related comorbidities such as cachexia. However, follow-up of tumor take, tumor growth and detection of therapeutic effects is difficult, time consuming and requires a vast number of animals in orthotopic models. Here, we describe a solution for the fully automatic segmentation and quantification of orthotopic lung tumor volume and mass in whole-body mouse computed tomography (CT) scans. The goal is to drastically enhance the efficiency of the research process by replacing time-consuming manual procedures with fast, automated ones. A deep learning algorithm was trained on 60 unique manually delineated lung tumors and evaluated by four-fold cross validation. Quantitative performance metrics demonstrated high accuracy and robustness of the deep learning algorithm for automated tumor volume analyses (mean dice similarity coefficient of 0.80), and superior processing time (69 times faster) compared to manual segmentation. Moreover, manual delineations of the tumor volume by three independent annotators was sensitive to bias in human interpretation while the algorithm was less vulnerable to bias. In addition, we showed that besides longitudinal quantification of tumor development, the deep learning algorithm can also be used in parallel with the previously published method for muscle mass quantification and to optimize the experimental design reducing the number of animals needed in preclinical studies. In conclusion, we implemented a method for fast and highly accurate tumor quantification with minimal operator involvement in data analysis. This deep learning algorithm provides a helpful tool for the noninvasive detection and analysis of tumor take, tumor growth and therapeutic effects in mouse orthotopic lung cancer models.


Sign in / Sign up

Export Citation Format

Share Document